Comparison of Spinal Cord Magnetic Resonance Imaging Features Among Children With Acquired Demyelinating Syndromes
Authors: Giulia Fadda, Cesar A. Alves, Julia O’Mahony, Denise A. Castro, E. Ann Yeh, Ruth Ann Marrie, Douglas L. Arnold, Patrick Waters, Amit Bar-Or, Arastoo Vossough, Brenda Banwell, Brenda Banwell, Amit Bar-Or, Douglas L. Arnold, Ruth Ann Marrie, E. Ann Yeh, Mark Awuku, J. Burke Baird, Virender Bhan, David Buckley, David Callen, Mary B. Connolly, Marie-Emmanuelle Dilenge, Asif Doja, Simon Levin, Anne Lortie, E. Athen MacDonald, Jean K. Mah, Brandon Meaney, David Meek, Daniela Pohl, Guillaume Sebire, Sunita Venkateswaran, Amy Waldman, Katherine Wambera, Ellen Wood, Jerome Yager
Journal: JAMA Network Open (2021)

<h3>Importance</h3> The recognition of magnetic resonance imaging (MRI) features associated with distinct causes of myelitis in children is essential to guide investigations and support diagnostic categorization. <h3>Objective</h3> To determine the clinical and MRI features and outcomes associated with spinal cord involvement in pediatric myelin oligodendrocyte glycoprotein antibody–associated disease (MOGAD), multiple sclerosis (MS), and seronegative monophasic myelitis. <h3>Design, Setting, and Participants</h3> In this cohort study, participants were recruited between 2004 and 2017 through the multicenter Canadian Pediatric Demyelinating Disease Study, which enrolled youth younger than 18 years presenting within 90 days of an acquired demyelinating syndrome. Of the 430 participants recruited, those with lesions on available spine MRI and anti-MOG testing performed on archived samples obtained close to clinical presentation were selected. Participants with poor-quality images and final diagnoses of nondemyelinating disease, anti–aquaporin 4 antibody positivity, and relapsing seronegative myelitis were excluded. Data analysis was performed from December 2019 to November 2020. <h3>Main Outcomes and Measures</h3> Spinal cord involvement was evaluated on 324 MRI sequences, with reviewers blinded to clinical, serological, and brain MRI findings. Associated clinical features and disability scores at 5 years of follow-up were retrieved. Results were compared between groups. <h3>Results</h3> A total of 107 participants (median [IQR] age at onset, 11.14 [5.59-13.39] years; 55 girls [51%]) were included in the analyses; 40 children had MOGAD, 21 had MS, and 46 had seronegative myelitis. Longitudinally extensive lesions were very common among children with MOGAD (30 of 40 children [75%]), less common among those with seronegative myelitis (20 of 46 children [43%]), and rare in children with MS (1 of 21 children [5%]). Axial gray matter T2-hyperintensity (ie, the H-sign) was observed in 22 of 35 children (63%) with MOGAD, in 14 of 42 children (33%) with seronegative myelitis, and in none of those with MS. The presence of leptomeningeal enhancement was highly suggestive for MOGAD (22 of 32 children [69%] with MOGAD vs 10 of 38 children [26%] with seronegative myelitis and 1 of 15 children [7%] with MS). Children with MOGAD were more likely to have complete lesion resolution on serial images (14 of 21 children [67%]) compared with those with MS (0 of 13 children). <h3>Conclusions and Relevance</h3> These findings suggest that several features may help identify children at presentation who are more likely to have myelitis associated with MOGAD. Prominent involvement of gray matter and leptomeningeal enhancement are common in pediatric MOGAD, although the pathological underpinning of these observations requires further study.